FA regimen as the consolidation chemotherapy in treatment of acute myeloid leukemia (AML): a multi-center, randomised clinical trial.
Phase of Trial: Phase IV
Latest Information Update: 24 Apr 2016
At a glance
- Drugs Cytarabine (Primary) ; Fludarabine (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 21 May 2012 Planned end date changed from 1 May 2012 to 31 May 2015 as reported by Chinese Clinical Trial Register.
- 23 Aug 2011 New trial record